Release of endothelial cell-associated heparan sulfate proteoglycan by activated T cells
Geller, R.L.; Ihrcke, N.S.; Platt, J.L.
Transplantation 57(5): 770-774
1994
ISSN/ISBN: 0041-1337 PMID: 8140646 Document Number: 431219
Document emailed within 1 workday
Related Documents
Nishinaga, M.; Shimada, K. 1994: Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells Rinsho Byori. Japanese Journal of Clinical Pathology 42(4): 340-345D'hondt, C. 2008: Role for heparan sulfate proteoglycan in thrombin-induced calcium transients and nitric oxide production in aortic endothelial cells Thrombosis and Haemostasis 100(3): 374-376
Bruno, E.; Luikart, S.D.; Long, M.W.; Hoffman, R. 1995: Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines Experimental Hematology 23(11): 1212-1217
Wilson, J.G.; Fearon, D.T.; Stevens, R.L.; Seno, N.; Austen, K.F. 1984: Inhibition of the function of activated properdin by squid chondroitin sulfate e glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate e proteoglycan Journal of Immunology 132(6): 3058-3063
Khedun, S.M.; Naicker, T.; Moodley, J.; Gathiram, P. 2002: Urinary heparan sulfate proteoglycan excretion in black African women with pre-eclampsia Acta Obstetricia et Gynecologica Scandinavica 81(4): 308-312
Pinhal, M.A.; Santos, I.A.; Silva, I.F.; Dietrich, C.P.; Nader, H.B. 1995: Minimum fragments of the heparin molecule able to produce the accumulation and change of the sulfation pattern of an antithrombotic heparan sulfate from endothelial cells Thrombosis and Haemostasis 74(4): 1169-1174
Mahley, R.W. 1996: Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease Israel Journal of Medical Sciences 32(6): 414-429
Maniscalco, W.M.; Campbell, M.H. 1994: Transforming growth factor-beta induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells American Journal of Physiology 266(6 Pt 1): L672-L680
Del Papa, N.; Meroni, P.L.; Tincani, A.; Harris, E.N.; Pierangeli, S.S.; Barcellini, W.; Borghi, M.O.; Balestrieri, G.; Zanussi, C. 1992: Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells Clinical and Experimental Rheumatology 10(1): 37-42
Robertson, N.P.; Starkey, J.R.; Hamner, S.; Meadows, G.G. 1989: Tumor cell invasion of three-dimensional matrices of defined composition: evidence for a specific role for heparan sulfate in rodent cell lines Cancer Research 49(7): 1816-1823
Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1991: Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin Seminars in Thrombosis and Hemostasis 17(Suppl 1): 60-64
Phan, C.; McMahon, A.W.; Nelson, R.C.; Elliott, J.F.; Murray, A.G. 1999: Activated lymphocytes promote endothelial cell detachment from matrix: a role for modulation of endothelial cell beta 1 integrin affinity Journal of Immunology 163(8): 4557-4563
Gordon, M.Y.; Riley, G.P.; Clarke, D. 1988: Heparan sulfate is necessary for adhesive interactions between human early hemopoietic progenitor cells and the extracellular matrix of the marrow microenvironment Leukemia 2(12): 804-809
Mizutani, K.; Kawashima, S.; Ueyama, T.; Sakoda, T.; Takeuchi, S.; Kobayashi, S.; Yokoyama, M.; Hayashi, Y.; Itoh, H. 2001: Heparin and heparan sulfate inhibit extracellular signal-regulated kinase activation and myocardial cell hypertrophy induced by endothelin-1 Kobe Journal of Medical Sciences 47(2): 47-58
Blaser, C.; Kaufmann, M.; Pircher, H. 1998: Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin Journal of Immunology 161(12): 6451-6454
Havel, M.P.; Griesmacher, A.; Weigel, G.; Owen, A.; Simon, P.; Müller, M.M.; Wolner, E. 1992: Aprotinin decreases release of 6-keto-prostaglandin F1 alpha and increases release of thromboxane B2 in cultured human umbilical vein endothelial cells Journal of Thoracic and Cardiovascular Surgery 104(3): 654-658
Inatani, M. 2011: Role of heparan sulfate in axon guidance Seikagaku. Journal of Japanese Biochemical Society 83(3): 224-230
Li, L.M.; Nicolson, G.L.; Fidler, I.J. 1991: Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells Cancer Research 51(1): 245-254
Capecchi, P.L.; Ceccatelli, L.; Laghi Pasini, F.; Di Perri, T. 1993: Inhibition of neutrophil function in vitro by heparan sulfate International Journal of Tissue Reactions 15(2): 71-76
Kuhn, M.; Otten, A.; Frölich, J.C.; Förstermann, U. 1991: Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells Journal of Pharmacology and Experimental Therapeutics 256(2): 677-682